Astral Systems
Develops multi-state fusion technology for medical radioisotopes and commercial applications
£23MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops multi-state fusion technology for medical radioisotopes and commercial applications
Develops precision medicines for inflammatory and immune-mediated diseases using AI-powered patient cell analysis
Builds wellness apps for women's health, habit-building, and breaking compulsive behaviors
Develops AI-powered compliance automation for beauty and consumer goods companies across global markets
Provider of physical AI for warehouse robotics
Generates molecular data for drug development
Develops space-based solar energy systems
Develops an AI-powered bioproduction platform for industrial ingredients